Welcome to McCormack Pharma
Breaking News!
CEME:
When a drug’s intracellular footprint doesn’t add up
Keith McCormack shows that when a drug’s intracellular footprint is not consistent with prevailing dogma, then we must consider the possibility of a mechanism of action about which we know nothing!
-
CEME: the idea explained
Three quick articles explaining what CEME is, how it works, and why it is the investment that companies cannot afford to pass up.
-
CEME: success stories
Real-world case histories that show how CEME has revitalised drug brands, improved patient treatment… and saved lives.
-
CEME: What our clients say
McCormack has been providing its clients with profitable, cutting-edge information for over 30 years. Here's what they say about us.